Metraipolis › archive › dc_d2607356b780

Development and In Vitro Evaluation of Gefitinib-Salicylic Acid Nanocrystals for Improved Bioavailability — Europe PMC PMID:42198266

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42198266
DOI
10.3390/pharmaceutics18050572
License (as archived)
solo-consultazione
Archived
2026-11-02T17:42:24.854Z
SHA-256 of the archived text
0fccb5a551da8207efafe906dfd7d018756f49e0f1b2c240a583369897971702
Stable URL of this page
https://metraipolis.com/documento/dc_d2607356b780

How to cite

Development and In Vitro Evaluation of Gefitinib-Salicylic Acid Nanocrystals for Improved Bioavailability — Europe PMC PMID:42198266 — Europe PMC (en), https://europepmc.org/article/MED/42198266 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d2607356b780 (Metraipolis archive dc_d2607356b780, sha256 0fccb5a551da8207efafe906dfd7d018756f49e0f1b2c240a583369897971702)
BibTeX
@misc{dcd2607356b780,
  title = {Development and In Vitro Evaluation of Gefitinib-Salicylic Acid Nanocrystals for Improved Bioavailability — Europe PMC PMID:42198266},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42198266},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d2607356b780; sha256 0fccb5a551da8207efafe906dfd7d018756f49e0f1b2c240a583369897971702},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42198266. Agents can read the archived copy with the MCP tool read_document.